Skip to content

BIO - BIO-RAD LABORATORIES, INC. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchB

Bio-Rad Laboratories Inc

BIO · NYSE

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

B

BIOBio-Rad Laboratories Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $380.71
52-wk low: $236.73
Prev close: $291.79
Mkt cap: $10.07B
P/E: 44.5x
Fwd P/E: 39.8x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$2.0B

FE
First Eagle
Q2 2026 13F
$765.2M
position
AI
Ariel Investments
Q2 2026 13F

Earnings

Reported Aug 4, 2026

Earnings came in 12.0% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

Richly priced and running thin margins.

Net margin: 8.6%
P/E: 44.45
Forward P/E: 39.84
Market cap: $10.1B

Valuation

P/S3.89
P/B1.36

Quality

Operating margin11.2%

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: BIO
Exchange: NYSE
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
Market cap: $10.07B
Beta: 1.05

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Beta

1.05

P/S

3.9x

P/B

1.4x

Profit margin

+8.6%

Op margin

+11.2%

ROE

+3.1%

$239.8M

position

AQ

AQR

Q2 2026 13F

$56.0M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for BIO

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

$2.62+12.0%

$2.34 expected

Next report

What the street expects next

EPS expected

$2.23

$2.12 to $2.35

Revenue expected

$650.6M

4 analysts

Last 30 days

0up2down

Analysts cutting estimates

Estimate drift

0.08

Change in 30 days

ROE3.1%

ROA1.7%

Growth

Beta1.05